Brief Title
Talent Converter Post-Approval Study
Official Title
Talent Converter Post-Approval Study
Brief Summary
The primary endpoint is successful secondary endovascular treatment with the Talent Converter stent graft of subjects having received prior endovascular repair of infrarenal abdominal aortic or aortoiliac aneurysms using the Talent or AneuRx Bifurcated Stent Grafts, in which there is inadequate proximal fixation, seal, overlapping of modular components or unattainable contralateral limb cannulation. Treatment success is defined as a composite of successful vessel access, successful insertion of the delivery system, successful deployment of the Converter stent graft at the intended treatment site and absence of Type I endoleak at the 1 month follow-up visit.
Detailed Description
Converter PAS is an observational study. Patients will receive treatment regardless of study participation. In some cases, patients will be enrolled retrospectively, post implantation.
Study Type
Observational
Primary Outcome
Number of Subjects With Successful Secondary Endovascular Treatment
Condition
Abdominal Aortic Aneurysms
Intervention
Talent Converter Stent Graft and Talent Occluder with Occluder Delivery System
Study Arms / Comparison Groups
Participants with Successful Secondary Endovascular Treatment
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Device
Estimated Enrollment
20
Start Date
April 2010
Completion Date
September 29, 2017
Primary Completion Date
June 2013
Eligibility Criteria
Inclusion Criteria: 1. Subjects in whom a vessel access procedure was/will be performed with the attempted introduction of the Talent Converter Stent Graft for use according to the indications for use in the Instructions for Use (IFU) 0-365 days prior to enrollment. 2. Subjects who are able to understand the nature of the study and give voluntary informed consent. 3. Subjects who are available for follow-up visits. 4. Subjects 18 years of age or older. Exclusion Criteria: 1. Subjects in whom an attempted treatment was/will be performed with the Talent Converter Stent Graft other than (i.e., primary AUI) as a secondary endovascular intervention for patients having received prior endovascular repair with either a Talent or AneuRx bifurcated stent graft. 2. Subjects in whom an attempted treatment was/will be performed with the Talent Converter Stent Graft as a secondary endovascular intervention for patients having received prior endovascular repair with a bifurcated stent graft other than (i.e., Cook Zenith or Gore Excluder) a Talent or AneuRx bifurcated stent graft.
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
, ,
Administrative Informations
NCT ID
NCT01129609
Organization ID
Investigational Plan #119
Responsible Party
Sponsor
Study Sponsor
Medtronic Cardiovascular
Study Sponsor
, ,
Verification Date
October 2021